Abstract
Purposes
Brachytherapy has been indicated as an alternative option for treating cystic craniopharyngiomas. Despite the difficulties regarding the complex nuclear infrastructure and consequent small number of brachytherapy studies, recent discoveries relating tumour characteristics to sensitivity to brachytherapy have stimulated this extensive systematic review and meta-analysis of the recent results aiming to summarise its efficacy and complications.
Methods
The systematic review was structured using PRISMA statements. The MEDLINE database was systematically reviewed from March 2010 to February 2021 to identify qualified trials dealing with radioisotope brachytherapy in cystic craniopharyngiomas in the paediatric population, emphasising tumour control rates and complications.
Results
A total of 228 individuals were analysed, of which 66 were children. The minimum average follow-up was 5 years. Considering the paediatric trials, partial and complete responses were achieved in 89% of patients with exclusively cystic lesions, compared to 58% in non-exclusively cystic lesions. The former observed progression in 3% of patients, while in the latter, 35% was reported. Visual and endocrine improvement reached 64% and 20%, respectively, in the first group, in contrast to 48% and 7% in the second group, respectively. There were similar results considering the non-exclusive paediatric series, but with less expressive numbers.
Conclusion
These results reinforce the positive impact of radioisotope brachytherapy in the treatment of predominant monocystic or multicystic craniopharyngiomas, especially in the paediatric population, grounded by impressive tumour control rates, lower morbidities and single application in the majority of the cases. In the future, specific morphological tumour characteristics might be considered for a more assertive patient selection.
Similar content being viewed by others
References
Cossu G, Jouanneau E, Cavallo LM et al (2020) Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Acta Neurochir 162:1159–1177. https://doi.org/10.1007/s00701-020-04265-1
Iannalfi A, Fragkandrea I, Brock J, Saran F (2013) Radiotherapy in craniopharyngiomas. Clin Oncol 25(11):654–667. https://doi.org/10.1016/j.clon.2013.07.005
Alexandraki KI, Kaltsas GA, Karavitaki N, Grossman AB (2009) The medical therapy of craniopharyngiomas: the way ahead. J Clin Endocrinol Metab 104(12):5751–5764. https://doi.org/10.1210/jc.2019-01299. (PMID: 31369091)
Bogusz A, Muller HL (2018) Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert Rev Neurother 18(10):793–806. https://doi.org/10.1080/14737175.2018.1528874
Karavitaki N (2014) Management of craniopharyngiomas. J Endocrinol Invest 37(3):219–228. https://doi.org/10.1007/s40618-013-0050-9
Müller HL, Merchant TE, Puget S, Martinez-Barbera JP (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 13(5):299–312. https://doi.org/10.1038/nrendo.2016.217
Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL (2015) Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol 17(7):1029–1038. https://doi.org/10.1093/neuonc/nov044
Bartels U, Laperriere N, Bouffet E, Drake J (2012) Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol 3:1–2. https://doi.org/10.3389/fendo.2012.00039
Cáceres A (2005) Intracavitary therapeutic options in the management of cystic craniopharyngioma. child's nervous system 21(8–9):705–718. https://doi.org/10.1007/s00381-005-1227-0
Mrowczynski OD, Langan ST, Rizk EB (2018) Craniopharyngiomas: a systematic review and evaluation of the current intratumoral treatment landscape. Clin Neurol Neurosurg 166:124–130. https://doi.org/10.1016/j.clineuro.2018.01.039
Moussa AH, Kerasha AA, Mahmoud ME (2013) Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study. Br J Neurosurg 27(3):370–373. https://doi.org/10.3109/02688697.2012.741732
Spaziante R, De Divitiis E, Irace C, Cappabianca P, Caputi F (1989) Management of primary or recurring grossly cystic craniopharyngioma by means of draining system. Acta Neurochir (Wein) 97(3–4):95–106
Chang H, Zhang J, Cao W, Wang Y, Zhao H, Liu R, Guo S (2018) Drug distribution and clinical safety in treating cystic craniopharyngiomas using intracavitary radiotherapy with phosphorus-32 colloid. Oncol Lett 15(4):4997–5003. https://doi.org/10.3892/ol.2018.7981
Denis-Bacelar AM, Romanchikova M, Chittenden S, Saran FH, Mandeville H, Du Y, Flux GD (2013) Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumors. Eur J Nucl Med Mol Imaging 40(10):1532–1541. https://doi.org/10.1007/s00259-013-2451-6
Enriquez-Marulanda A, Sierra-Ruiz M, Pabón LM, Lobato-Polo J (2016) Intracavitary irradiation as a safe alternative for cystic craniopharyngiomas: case report and review of the literature. Case Rep Med 2016:3601395. https://doi.org/10.1155/2016/3601395
Leksell L (1951) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102(4):316–319
Babaei M, Ghahramani-Asl R, Sadoughi H, Sardari D, Shahzadi S (2018) Evaluation of Bremsstrahlung radiation dose in stereotactically radiocolloid therapy of cystic craniopharyngioma tumors with 32P radio-colloid. Australas Phys Eng Sci Med 41(3):697–771. https://doi.org/10.1007/s13246-018-0665-4
Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54(4):813–20; discussion 820–2. https://doi.org/10.1227/01.neu.0000114262.30035.af
Hu C, Chen J, Meng Y, Zhang J, Wang Y, Liu R, Yu X (2018) Phosphorus-32 interstitial radiotherapy for recurrent craniopharyngioma. Medicine 97(26):11136–11140. https://doi.org/10.1097/md.0000000000011136
Julow JV (2012) Intracystic irradiation for craniopharyngiomas. Pituitary 16(1):34–45. https://doi.org/10.1007/s11102-012-0442-4
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA Statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100
Hozo SP, Djubegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5(1):1–10. https://doi.org/10.1186/1471-2288-5-13
Salkind N (2010) Encyclopedia of Research Design. SAGE Publications, Inc
Barriger RB, Chang A, Lo SS, Timmerman RD, Desrosiers C, Boaz JC, Fakiris AJ (2011) Phosphorus-32 therapy for cystic craniopharyngiomas. Radiotherapy And Oncology 98(2):207–212. https://doi.org/10.1016/j.radonc.2010.12.001
Maarouf M, Majdoub FE, Fuetsch M, Hoevels M, Lehrke R, Berthold F, Voges J, Sturm V (2015) Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children. Strahlenther Onkol 192(3):157–165. https://doi.org/10.1007/s00066-015-0910-7
Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33(2):437–446. https://doi.org/10.1016/0360-3016(95)00175-X
Vanhauwaert D, Hallaert G, Baert E, Van Roost D, Okito JP, Caemaert J (2013) Treatment of cystic craniopharyngioma by endocavitary instillation of yttrium90 radioisotope–still a valuable treatment option. J Neurol Surg Part A Cent Eur Neurosurg 74(5):307–312. https://doi.org/10.1055/s-0033-1341413
Kickingereder P, Maarouf M, Majdoub FE, Fuetsch M, Lehrke R, Wirths J, Luyken K, Schomaecker K, Treuer H, Voges J (2012) Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients. Journal of Neurooncology 109(2):365–374. https://doi.org/10.1007/s11060-012-0902-8
Yu X, Zhang J, Liu R, Wang Y, Wang H, Wang P, Chen J, Liu S (2015) Interstitial radiotherapy using phosphorus-32 for giant posterior fossa cystic craniopharyngiomas. J Neurosurg Pediatr 15(5):510–518. https://doi.org/10.3171/2014.10.peds14302
Zhao R, Deng J, Liang X, Zeng J, Chen X, Wang J (2010) Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation. Childs Nerv Syst 26(50):669–674. https://doi.org/10.1007/s00381-009-1025-1
Ansari SF, Moore RJ, Boaz JC, Fulkerson DH (2016) Efficacy of phosphorus-32 brachytherapy without external-beam radiation for long-term tumor control in patients with craniopharyngioma. J Neurosurg Pediatr 17(4):439–445. https://doi.org/10.3171/2015.8.peds15317
Backlund EO (1989) Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas. J Neurosurg Sci 33(1):95–97
Backlund EO, Axelsson B, Bergstrand CG et al (1989) Treatment of craniopharyngioma: the stereotactic approach in a ten to twenty-three years’ perspective. I. Surgical, radiological and ophthalmological aspects. Acta Neurochir (Wien) 99:11–19
Backlund EO (1994) Treatment of craniopharyngiomas: the multimodality approach. Pediatr Neurosurg 21(Suppl 1):82–89. https://doi.org/10.1159/000120867
Julow JV, Backlund EO, Lányi F, Hajda M, Bálunt K, Nyáry I, Szeifert GT (2007) Long-term resuts and late complications after intracavitary ytrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery 61(2):288–296. https://doi.org/10.1227/01.neu.0000255528.68963.ef
Van den Berge JH, Blaauw G, Breeman WA, Rahmy A, Wijngaarde R (1992) Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 77(4):545–550. https://doi.org/10.3171/jns.1992.77.4.0545
Voges J, Sturm V, Lehrke R, Treuer H, Gauss C, Berthold F (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta- emitting radioactive sources. Neurosurgery 40(2):263–269. https://doi.org/10.1097/00006123-199702000-00006
Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, Dhellemmes P (2008) Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery 63(6):1045–52; discussion 1052–3. https://doi.org/10.1227/01.NEU.0000335786.10968.2F
Kiehna EN, Merchant TE (2010) Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus 28(4):10–14. https://doi.org/10.3171/2010.1.focus09297
Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM (2017) Very long-term sequelae of craniopharyngioma. Eur J Endocrinol 176(6):755–767. https://doi.org/10.1530/EJE-17-0044
Funding
The researcher funded the cost related to statistical analysis and English translation. There were no other costs.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain human participant studies performed by the authors.
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guimarães, M.M., Cardeal, D.D., Teixeira, M.J. et al. Brachytherapy in paediatric craniopharyngiomas: a systematic review and meta-analysis of recent literature. Childs Nerv Syst 38, 253–262 (2022). https://doi.org/10.1007/s00381-021-05378-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-021-05378-3